Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Three of the most popular cardiovascular technologies to make news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made s
Feature

July 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magaz ...

Home July 06, 2020
Home
News | Cardiovascular Clinical Studies

July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption ...

Home July 01, 2020
Home
News | Heart Valve Technology

June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve ...

Home June 23, 2020
Home
News | Heart Valve Technology

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device ...

Home June 19, 2020
Home
Videos | Heart Valve Technology

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home June 10, 2020
Home
SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company of India focused on cardiology, announced it Hydra transcatheter aortic valve replacement (TAVR) device received European CE mark approval. It is indicated for the treatment of patients diagnosed with aortic stenosis. #SMT #HYDRA #TAVR
Feature | Heart Valve Technology

June 9, 2020 — SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company in India focused on ...

Home June 09, 2020
Home
News | Heart Valve Technology

June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter ...

Home June 08, 2020
Home
News | Structural Heart

May 29, 2020 — Neovasc Inc., developer of a minimally invasive transcatheter mitral valve replacement (TMVR) ...

Home May 29, 2020
Home
Videos | HRS

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 22, 2020
Home
News | Congenital Heart

May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were ...

Home May 21, 2020
Home
News | Heart Valve Technology

May 18, 2020 — The Edwards Lifesciences Corp. Pascal tricuspid transcatheter valve repair (TTVR) system received ...

Home May 18, 2020
Home
News | Atrial Fibrillation

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety ...

Home May 08, 2020
Home
Key TAVR Takeaways From ACC 2020
Feature | Heart Valve Technology | Dave Fornell, Editor

Some U.S. centers need improvement in their outcomes was the biggest takeaway from the five transcatheter aortic valve ...

Home April 20, 2020
Home
Subscribe Now